Skip to main content

Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98

Drug Recall

Official source record

Recall number
D-0521-2016
Event ID
72607
Classification
Class III
Status
Terminated
Recalling company
Teva Pharmaceutical Industries
Reason for recall
Labeling: Incorrect or Missing Lot AND/OR Exp Date.
Report date
December 23, 2015
Recall initiation date
October 20, 2015
Termination date
November 1, 2016
Distribution pattern
Nationwide

Drug product identifiers

Manufacturer
Teva Pharmaceuticals USA, Inc.
Brand name
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Generic name
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Substance names
HYDROCHLOROTHIAZIDE; IRBESARTAN
Product NDCs
0093-8232; 0093-8238
Package NDCs
0093-8232-56; 0093-8232-98; 0093-8238-56; 0093-8238-98
Route
ORAL

Where this information comes from

View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class III mean?

A situation in which use of or exposure to a product is not likely to cause adverse health consequences.

Is this recall still active?

According to the FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this medication?

Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.

Where can I find more official information?

The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.